Prognosis
Blood Beats Banking With CSL Becoming Australia Biggest Firm
This article is for subscribers only.
For a fresh perspective on the stories that matter for Australian business and politics, sign up for our new weekly newsletter.
Australia’s benchmark stock index has a new leader: A biotechnology firm that makes therapeutic products from human blood.